China now one of the world's largest heparin API producers and exporters; report

China, abundant in heparin raw materials, has become one of the world's largest heparin API producers and exporters, owing to the quality of heparin active pharmaceutical ingredient (API) having won international recognition gradually, according to a new report added to the offering of Reportlinker.com.

Due to the euro debt crisis, the global market suffered a deep recession. Coupled with that, the heparin export standard has been lifted, China's export volume of heparin API was no more than 105.2 tons in 2011, approximating 14.6 trillion units (measured by 140IU/mg), or around 45.9% of global demand during the same period.

Leading heparin API suppliers worldwide include Shenzhen Hepalink Pharmaceutical, Changzhou Qianhong Bio-Pharma, Yantai Dongcheng Biochemicals and Nanjing King-Friend Biochemical Pharmaceutical, which have ranked top four industrial players by export for several successive years, with the combined export value making up more than 70% of China's total export value of heparin.